A drug with the SMILES CCN(C(=O)CN1CCN(c2cccc(Cl)c2)CC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 1.157%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
CCN(C(=O)CN1CCN(c2cccc(Cl)c2)CC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
CCN(C(=O)CN1CCN(c2cccc(Cl)c2)CC1)c1c(N)n(Cc2ccccc2)c(=O)[nH]c1=O
N-(6-amino-1-benzyl-2,4-dioxopyrimidin-5-yl)-2-[4-(3-chlorophenyl)piperazin-1-yl]-N-ethylacetamide